A matter of life and cell death

被引:1304
作者
Evan, G [1 ]
Littlewood, T [1 ]
机构
[1] Imperial Canc Res Fund Labs, London WC2A 3PX, England
关键词
D O I
10.1126/science.281.5381.1317
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In multicellular organisms, mutations in somatic cells affecting critical genes that regulate cell proliferation and survival cause fatal cancers. Repair of the damage is one obvious option, although the relative inconsequence of individual cells in metazoans means that it is often a "safer" strategy to ablate the offending cell. Not surprisingly, corruption of the machinery that senses or implements DNA damage greatly predisposes to cancer. Nonetheless, even when oncogenic mutations do occur, there exist potent mechanisms that Limit the expansion of affected cells by suppressing their proliferation or triggering their suicide. Growing understanding of these innate mechanisms is suggesting novel therapeutic strategies for cancer.
引用
收藏
页码:1317 / 1322
页数:6
相关论文
共 148 条
  • [1] Adams PD, 1996, CURR TOP MICROBIOL, V208, P79
  • [2] Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo
    Agah, R
    Kirshenbaum, LA
    Abdellatif, M
    Truong, LD
    Chakraborty, S
    Michael, LH
    Schneider, MD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11) : 2722 - 2728
  • [3] Alarcon RM, 1996, CANCER RES, V56, P4315
  • [4] THE C-MYC PROTEIN INDUCES CELL-CYCLE PROGRESSION AND APOPTOSIS THROUGH DIMERIZATION WITH MAX
    AMATI, B
    LITTLEWOOD, TD
    EVAN, GI
    LAND, H
    [J]. EMBO JOURNAL, 1993, 12 (13) : 5083 - 5087
  • [5] Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250
  • [6] Failure to activate interleukin 1 beta-converting enzyme-like proteases and to cleave retinoblastoma protein in drug-resistant cells
    An, B
    Jin, JR
    Lin, P
    Dou, QP
    [J]. FEBS LETTERS, 1996, 399 (1-2) : 158 - 162
  • [7] Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L
    Aragane, Y
    Kulms, D
    Metze, D
    Wilkes, G
    Pöppelmann, B
    Luger, TA
    Schwarz, T
    [J]. JOURNAL OF CELL BIOLOGY, 1998, 140 (01) : 171 - 182
  • [8] ASKEW DS, 1991, ONCOGENE, V6, P1915
  • [9] ATTARDI LD, 1996, EMBO J, V15, P3702
  • [10] Berry DE, 1996, ONCOGENE, V12, P1809